Asian Diabetes Outcomes Prevention Trial
Conditions: Diabetes Mellitus; Cardiovascular Diseases Interventions: Drug: Renin-angiotensin-aldosterone system inhibitors; Drug: Beta blocker; Drug: SGLT2 Inhibitor - Sodium Glucose Cotransporter Subtype 2 Inhibitor Product Sponsors: National Heart Centre Singapore; Singapore General Hospital; Mackay Memorial Hospital; National Taiwan University Hospital; Peking University People's Hospital; Medanta, The Medicity, India; Public Health Foundation of India; Putrajaya Hospital, Malaysi a; Universiti Teknologi Mara Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Diabetes | Endocrinology | Heart | Hospitals | India Health | Research | SGLT2 Inhibitors | Singapore Health | Sodium